140 related articles for article (PubMed ID: 2371033)
1. Estrogen treatment of patients with established postmenopausal osteoporosis.
Lindsay R; Tohme JF
Obstet Gynecol; 1990 Aug; 76(2):290-5. PubMed ID: 2371033
[TBL] [Abstract][Full Text] [Related]
2. [Effect of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis].
Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harpe K
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):269-73. PubMed ID: 15059505
[TBL] [Abstract][Full Text] [Related]
3. The usefulness of bone turnover in predicting the response to transdermal estrogen therapy in postmenopausal osteoporosis.
Gonnelli S; Cepollaro C; Pondrelli C; Martini S; Monaco R; Gennari C
J Bone Miner Res; 1997 Apr; 12(4):624-31. PubMed ID: 9101374
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
[TBL] [Abstract][Full Text] [Related]
5. [The use of parenteral clodronate in elderly women with postmenopausal osteoporosis: compliance, effects on bone mineral density and on bone turnover].
Celi M; Balducci S; Schiappoli A; Caliumi C; Petramala L; Cerci S; Cotesta D; D'Erasmo E; Letizia C
Ann Ital Med Int; 2003; 18(2):89-98. PubMed ID: 12886826
[TBL] [Abstract][Full Text] [Related]
6. Prevention of bone loss by clodronate in early postmenopausal women with vertebral osteopenia: a dose-finding study.
Välimäki MJ; Laitinen K; Patronen A; Puolijoki H; Seppänen J; Pylkkänen L; Aranko SM; Sairanen S; Blåfield H; Rekiaro M; Väisänen K; Kormano M; Mäkinen L; Salmi J; Ala-Kaila K; Perttilä J; Vesterinen K; Koivunoro K;
Osteoporos Int; 2002 Dec; 13(12):937-47. PubMed ID: 12459936
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of the effectiveness of 17-beta-estradiol and calcitonin in women with postmenopausal bone loss].
Stĕpán J; Formánková J; Masatová A; Michalský M; Rosenová Z
Cas Lek Cesk; 1997 Apr; 136(8):242-8. PubMed ID: 9264868
[TBL] [Abstract][Full Text] [Related]
8. Long-term effect of calcium supplementation on bone loss in perimenopausal women.
Elders PJ; Lips P; Netelenbos JC; van Ginkel FC; Khoe E; van der Vijgh WJ; van der Stelt PF
J Bone Miner Res; 1994 Jul; 9(7):963-70. PubMed ID: 7942164
[TBL] [Abstract][Full Text] [Related]
9. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
Brodowska A
Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
[TBL] [Abstract][Full Text] [Related]
10. Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis.
Iwamoto J; Takeda T; Sato Y; Uzawa M
J Bone Miner Metab; 2005; 23(3):238-42. PubMed ID: 15838627
[TBL] [Abstract][Full Text] [Related]
11. Total calcium intake is associated with cortical bone mineral density in a cohort of postmenopausal women not taking estrogen.
Suzuki Y; Whiting SJ; Davison KS; Chilibeck PD
J Nutr Health Aging; 2003; 7(5):296-9. PubMed ID: 12917743
[TBL] [Abstract][Full Text] [Related]
12. The effects of plasma estradiol levels on increases in vertebral and femoral bone density following therapy with estradiol and estradiol with testosterone implants.
Garnett T; Studd J; Watson N; Savvas M; Leather A
Obstet Gynecol; 1992 Jun; 79(6):968-72. PubMed ID: 1579324
[TBL] [Abstract][Full Text] [Related]
13. Fluoride therapy for osteoporosis promotes a progressive increase in spinal bone density.
Farley SM; Libanati CR; Mariano-Menez MR; Tudtud-Hans LA; Schulz EE; Baylink DJ
J Bone Miner Res; 1990 Mar; 5 Suppl 1():S37-42. PubMed ID: 2339634
[TBL] [Abstract][Full Text] [Related]
14. [Effect of estrogen replacement therapy on the serum osteocalcin level in the postmenopausal and castrated women].
Honjo S; Mizunuma H; Soda M; Igarashi M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1571-6. PubMed ID: 2555424
[TBL] [Abstract][Full Text] [Related]
15. Prevention of bone loss following oophorectomy in premenopausal women: a retrospective assessment of the effects of oophorectomy and a prospective controlled trial of the effects of mestranol therapy.
Aitken JM; Hart DM; Lindsay R; Anderson JB; Smith DA; Wilson GM
Isr J Med Sci; 1976 Jul; 12(7):607-14. PubMed ID: 972015
[TBL] [Abstract][Full Text] [Related]
16. Menopausal changes in calcium balance performance.
Heaney RP; Recker RR; Saville PD
J Lab Clin Med; 1978 Dec; 92(6):953-63. PubMed ID: 739173
[TBL] [Abstract][Full Text] [Related]
17. [Influence of diet and physical activity on the course and therapy of osteoporosis].
Owecki M; Horst-Sikorska W; Baszko-Błaszyk D; Sowiński J
Pol Merkur Lekarski; 2002 Dec; 13(78):473-6. PubMed ID: 12666444
[TBL] [Abstract][Full Text] [Related]
18. Ipriflavone and low doses of estrogens in the prevention of bone mineral loss in climacterium.
Melis GB; Paoletti AM; Bartolini R; Tosti Balducci M; Massi GB; Bruni V; Becorpi A; Ottanelli S; Fioretti P; Gambacciani M
Bone Miner; 1992 Oct; 19 Suppl 1():S49-56. PubMed ID: 1422321
[TBL] [Abstract][Full Text] [Related]
19. [Osteoporosis and estrogens].
Metka M
Wien Med Wochenschr; 1990 Oct; 140(18-19):485-6. PubMed ID: 2251842
[TBL] [Abstract][Full Text] [Related]
20. [Effect of estriol and bone mineral density of lumbar vertebrae in elderly and postmenopausal women].
Nishibe A; Morimoto S; Hirota K; Yasuda O; Ikegami H; Yamamoto T; Fukuo K; Onishi T; Ogihara T
Nihon Ronen Igakkai Zasshi; 1996 May; 33(5):353-9. PubMed ID: 8741364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
